Thema
Letter
3.233
Case Reports
991
Research Support, Non-U.S. Gov't
448
Comment
435
Dermatologic Agents
191
Antibodies, Monoclonal, Humanized
119
Multicenter Study
89
Antibodies, Monoclonal
84
Antineoplastic Agents
82
Autoantibodies
68
Research Support, N.I.H., Extramural
64
Observational Study
62
Immunosuppressive Agents
61
Randomized Controlled Trial
55
Review
54
Immunoglobulin G
53
Tumor Necrosis Factor-alpha
50
Comparative Study
47
Biomarkers
46
Anti-Bacterial Agents
45
Photosensitizing Agents
42
FU77B4U5Z0
37
Methotrexate
37
Ustekinumab
37
YL5FZ2Y5U1
37
EC 2.7.11.1
36
Etanercept
36
OP401G7OJC
36
Antifungal Agents
35
Autoantigens
35
B72HH48FLU
35
Infliximab
35
420K487FSG
34
Membrane Proteins
34
dupilumab
34
Adalimumab
32
FYS6T7F842
32
Anti-Inflammatory Agents
31
Sunscreening Agents
30
EC 2.7.10.1
29
Evaluation Study
29
Biological Products
28
Interleukin-17
28
Non-Fibrillar Collagens
28
88755TAZ87
27
Aminolevulinic Acid
27
Proto-Oncogene Proteins B-raf
26
Glucocorticoids
25
Systematic Review
23
Immunologic Factors
22
mehr ...